本页面由Tiger Trade Technology Pte. Ltd.提供服务

Turnstone Biologics Corp.

0.3550
0.0000
成交量:- -
成交额:10.17万
市值:821.49万
市盈率:-0.17
高:0.3550
开:0.3550
低:0.3550
收:0.3550
52周最高:2.40
52周最低:0.2900
股本:2,314.07万
流通股本:1,993.03万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.0463
每股收益(LYR):-3.0749
净资产收益率:-126.71%
总资产收益率:-57.78%
市净率:0.56
市盈率(LYR):-0.12

数据加载中...

2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/31

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/16

重要事件披露

Form 8-K - Current report
2024/03/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/18

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/05

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/07/26

重要事件披露

Form 8-K - Current report
2023/07/24

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/18

SEC问询函

Form CORRESP - Correspondence
2023/07/18

SEC问询函

Form CORRESP - Correspondence
2023/07/17

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]